Media release
From:
JAMA
Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies
JAMA Network Open
Original Investigation
About The Study: In this large cohort study of successive pregnancies, influenza vaccination was not associated with increased risk of adverse perinatal outcomes, irrespective of interpregnancy interval and vaccine type. Findings support recommendations to vaccinate pregnant people or those who might be pregnant during the influenza season.
Journal/
conference:
JAMA Network Open
Organisation/s:
Kaiser Permanente Southern California, USA
Funder:
This research was funded by the Centers for Disease Control and Prevention (CDC) as part of
the Vaccine Safety Datalink project (contract No. 200-2012-53580). Conflict of Interest Disclosures: Dr Getahun reported receiving grants from the National Institutes of Health
(NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Garfield
Memorial Fund, Hologic, and Johnson & Johnson outside the submitted work. Dr Sy reported receiving grants
from Moderna, GlaxoSmithKline, and Dynavax outside the submitted work. Dr Glanz reported receiving grants
from Hillivax outside the submitted work. Dr Vazquez-Benitez reported receiving grants from AbbVie and Sanofi
Pasteur outside the submitted work. Dr Nelson reported receiving personal fees from Harvard Pilgrim Health Care
outside the submittedwork. Dr Nguyen reported receiving grants from CSL Seqirus, ModernaTX, and GSK outside
the submittedwork. Dr Qian reported receiving grants from Moderna, GlaxoSmithKline, and Dynavax outside the
submitted work. No other disclosures were reported. Role of the Funder/Sponsor: As the funding organization, the CDC reviewed and approved the study protocol,
assisted with data collection and interpretation, and contributed to the writing of the manuscript. The CDC had no
role in data management or analysis.
Sign In
International
